– UK, London – Lloyds Banking Group plc (LON: LLOY) today announced the appointment of Scott Wheway to its Board as a Non-Executive Director and as a Non-Executive Director of Scottish Widows Group with effect from 1 August 2022.
Subject to regulatory approval, he should also be appointed as Chair of Scottish Widows Group with effect from 12 September 2022.
“Scott will bring a depth and breadth of knowledge and experience of large-scale banking and insurance to his roles with the Group. His track record as a non-executive and executive in customer-centric companies complements the Group’s strategy and will help us deliver the right outcomes for customers. I look forward to welcoming him to the Group. I would also like to thank Sophie O’Connor for taking on the role of interim Chair of Scottish Widows Group since Nick Prettejohn stepped down from the role in September last year.” said Group Chair, Robin Budenberg.
About Scott Wheway
Scott Wheway is currently Chair of Centrica plc and AXA UK plc; however, he will step down from his role as Chair of AXA UK plc today, 30 June 2022, while remaining Chair of Centrica plc. Over the last 15 years Scott has gained significant financial services board experience, having chaired Aviva Insurance Limited and served as a non-executive director of Aviva plc between 2007 and 2016. He spent seven years on the board of Santander UK plc, where he was the senior independent director until 30 September 2020. Scott worked as an executive in the retail sector for over 25 years where he held positions including CEO of Best Buy Europe, managing director of Boots the Chemist plc and a number of senior executive positions at Tesco plc.
For more information : https://www.lloydsbankinggroup.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.